Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Document › Details

OncoDNA S.A.. (4/27/16). "Press Release: OncoDNA Launches Its New Product OncoTRACE".

Organisation Organisation OncoDNA S.A.
  Group OncoDNA (Group)
Products Product OncoTRACE testing services
  Product 2 circulating tumor cell technology (CTC technology)
     


On 27 April 2016, OncoDNA has launched its new product called OncoTRACE. It’s the first test in the world which is really personalized. It uses a blood sample to monitor the progression of a patient's tumor and to rapidly assess treatment effectiveness. The purpose of this innovative, non-invasive test is to sequence circulating tumor DNA, that is genetic material which has escaped from the tumor and is found in the blood. OncoTRACE is the logical follow-up to OncoDEEP . During the first OncoDEEP analysis, the specific characteristics of the tumor, i.e. the mutations present, are identified. With OncoTRACE, a test is done on a blood sample and the mutations can be monitored. At the same time, the appearance of new mutations linked to treatment resistance can be tracked. The results obtained from this much less invasive technique can therefore monitor the evolution of the tumor, evaluate treatment effectiveness and hence identify any recurrence earlier than classic technologies can at present. The analysis can be done several times, depending on the clinical protocol chosen by the oncologist. Based on this new information OncoDNA can suggest other treatment options if necessary.

You will find the press articles and video via these links :

http://www.lalibre.be/economie/digital/l-ennemi-d-oncodna-c-est-le-cancer-5721d55d35702a22d6d5e22f#7957c

http://kanaalz.knack.be/nieuws/simpele-bloedtest-kan-evolutie-kanker-volgen/video-normal-696813.html

http://canalz.levif.be/news/oncodna-passe-a-la-vitesse-superieure-27-04-16/video-normal-494545.html?utm_content=buffer23a23&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

http://www.lecho.be/entreprises/pharma_biotechnologie/Un_test_sanguin_pour_suivre_l_efficacite_des_traitements_contre_les_cancers.9759779-3002.art?utm_medium=twitter&utm_source=dlvr.it

http://www.telesambre.be/traitement-du-cancer-une-premiere-mondiale-a-gosselies_d_17597.html

http://www.rtl.be/belrtl/Emission/sante-vous-bien-1275.aspx

http://www.rtbf.be/info/regions/detail_une-premiere-mondiale-dans-la-lutte-contre-le-cancer-lancee-a-charleroi?id=9281670

http://www.dhnet.be/regions/charleroi-centre/cancer-une-prise-de-sang-qui-en-dit-long-5720e20a35702a22d6cfe38c

http://www.lanouvellegazette.be/1559581/article/2016-04-27/gosselies-oncodna-presente-ses-methodes-de-traitement-et-de-suivi-du-cancer

   
Record changed: 2016-09-04

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for OncoDNA (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top